Filing Details

Accession Number:
0000950103-24-006446
Form Type:
13D Filing
Publication Date:
2024-05-07 20:00:00
Filed By:
Ase Technology Holding Co., Ltd.
Company:
Ainos Inc.
Filing Date:
2024-05-08
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
ASE Technology Holding Co., Ltd. ( ASX ) 0 2,312,077 0 2,312,077 2,312,077 27.4%
ASE Test, Inc. ( ASE Test Taiwan ) 0 2,312,077 0 2,312,077 2,312,077 27.4%
Filing

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934
(Amendment No. )*

 

Ainos, Inc.

(Name of Issuer)

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

00902F303

(CUSIP Number)

 

Joseph Tung

Room 1901, No. 333, Section 1 Keelung Rd.

Taipei, 110, Taiwan,

Republic of China

Tel: +886-2-6636-5678

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

 

May 3, 2024

(Date of Event Which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. 00902F303

1

NAME OF REPORTING PERSON:

 

ASE Technology Holding Co., Ltd. (“ASX”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) ☒

(b) ☐

3

SEC USE ONLY:

 

4

SOURCE OF FUNDS (SEE INSTRUCTIONS):

 

WC

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Taiwan, Republic of China

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7

SOLE VOTING POWER:

 

0

8

SHARED VOTING POWER:

 

2,312,077 (1)

9

SOLE DISPOSITIVE POWER:

 

0

10

SHARED DISPOSITIVE POWER:

 

2,312,077 (1)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

2,312,077 (1)

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

 

27.4% (2)

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

 

CO

_______________________

(1)  Represents beneficial ownership of 2,312,077 shares of Common Stock, $0.01 par value (the “Common Stock”), of Ainos, Inc., a Texas corporation (the “Issuer”) consisting of the following: (i) 29,411 shares owned directly by ASE Test Taiwan (as defined below); (ii) 282,666 shares pursuant to the 2023 Agreement (as defined below) between ASE Test Taiwan and the Issuer; and (iii) 2,000,000 shares of common stock pursuant to the 2024 Agreement (as defined below) between ASE Test Taiwan and the Issuer. For further details, please see Item 3 and Item 6.

(2)  Based on the sum of (i) 6,144,506 shares of common stock outstanding as of March 31, 2024 as set forth in the Registration Statement on Form S-1 of the Issuer filed with the SEC on April 8, 2024, (ii) 282,666 shares of common stock convertible pursuant to the 2023 Agreement (as defined below) and (iii) 2,000,000 shares of common stock convertible pursuant to the 2024 Agreement (as defined below).

 

 

CUSIP No. 00902F303

1

NAME OF REPORTING PERSON:

 

ASE Test, Inc. (“ASE Test Taiwan”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) ☒

(b) ☐

3

SEC USE ONLY:

 

4

SOURCE OF FUNDS (SEE INSTRUCTIONS):

 

WC

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION:

 

Taiwan, Republic of China

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7

SOLE VOTING POWER:

 

0

8

SHARED VOTING POWER:

 

2,312,077 (1)

9

SOLE DISPOSITIVE POWER:

 

0

10

SHARED DISPOSITIVE POWER:

 

2,312,077 (1)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

2,312,077 (1)

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

 

27.4% (2)

14

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

 

CO

________________________

(1)Represents beneficial ownership of 2,312,077 shares of Common Stock, $0.01 par value (the “Common Stock”), of Ainos, Inc., a Texas corporation (the “Issuer”) consisting of the following: (i) 29,411 shares owned directly by ASE Test Taiwan (as defined below); (ii) 282,666 shares pursuant to the 2023 Agreement (as defined below) between ASE Test Taiwan and the Issuer; and (iii) 2,000,000 shares of common stock pursuant to the 2024 Agreement (as defined below) between ASE Test Taiwan and the Issuer. For further details, please see Item 3 and Item 6.
(2)Based on the sum of (i) 6,144,506 shares of common stock outstanding as of March 31, 2024 as set forth in the Registration Statement on Form S-1 of the Issuer filed with the SEC on April 8, 2024, (ii) 282,666 shares of common stock convertible pursuant to the 2023 Agreement (as defined below) and (iii) 2,000,000 shares of common stock convertible pursuant to the 2024 Agreement (as defined below).

 

 

 

 

Item 1. Security and Issuer

 

This Schedule 13D is being filed to reflect the acquisition by ASE Test Taiwan (as defined below) of a Convertible Note in the aggregate principal amount of $9,000,000 pursuant to a Convertible Note and Warrant Purchase Agreement entered into on May 3, 2024 (the “2024 Agreement”) between the Issuer and ASE Test Taiwan. The note bears 6% compound interest and has a three-year term. The note will be convertible into shares of Common Stock at a conversion price of $4.50 per share (or 2,000,000 shares), subject to customary anti-dilution adjustments.

 

This statement on Schedule 13D (this “Statement”) relates to the Common Stock, par value $0.01 per share of the Issuer. The address of the principal executive corporate offices of the Issuer is 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108.

 

Item 2. Identity and Background

 

(a)-(c) This Schedule 13D is being filed by (i) ASE Technology Holding Co., Ltd., a Taiwanese corporation (“ASX”), with a principal executive office at 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan, Republic of China, and (ii) its indirect wholly-owned subsidiary, ASE Test, Inc., a Taiwanese corporation (“ASE Test Taiwan”), with a principal executive office at 10, West 5th Street, Nanzih Dist., Kaohsiung, 811, Taiwan (ASX and ASE Test Taiwan, collectively, the “Reporting Persons”). ASE Test Taiwan is directly wholly-owned by Advanced Semiconductor Engineering, Inc., a Taiwan company, which is itself directly held by ASX.

 

The principal business of ASX includes semiconductor packaging, design and production of interconnect materials, front-end engineering testing, wafer probing, and final testing services, as well as electronic manufacturing services. The principal business of ASE Test Taiwan is providing semiconductor testing services.

 

For disclosure relating to the directors and executive officers of ASX and ASE Test Taiwan, see Appendix A hereto.

 

(d) During the last five years, none of the Reporting Persons nor any director or executive officer of the Reporting Persons have been convicted in a criminal proceeding.

 

(e) During the last five years, none of the Reporting Persons nor any director or executive officer of Reporting Persons was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

(f) The Reporting Persons are organized in Taiwan, Republic of China.

 

Item 3. Source and Amount of Funds or Other Consideration

 

On May 3, 2024, ASE Test Taiwan entered into a Convertible Note and Warrant Purchase Agreement with the Issuer pursuant to which ASE Test Taiwan purchased from the Issuer a Convertible Note in the aggregate principal amount of $9,000,000. The note bears 6% compound interest and has a three-year term. The note will be convertible into shares of Common Stock at a conversion price of $4.50 per share (or 2,000,000 shares), subject to customary anti-dilution adjustments. As part of the transaction, ASE Test Taiwan will receive a five-year common stock purchase warrant which will vest and become exercisable on the first day following a six-month period from the date of issue. The warrant may be exercised for up to 500,000 shares of Common Stock at a price of $4.50 per share, customary to anti-dilution adjustments.

 

The purchase of the Convertible Note was funded by ASE Test Taiwan with cash on hand.

 

Item 4. Purpose of Transaction

 

The purpose of the acquisition was to make a financial investment in the Issuer.

 

 

 

The Reporting Persons may engage in discussions with management, the board of directors of the Issuer (the “Board”), other shareholders of the Issuer and other relevant parties concerning the business, assets, capitalization, financial condition, operations, management, strategy, potential business combinations and strategic alternatives, and future plans of the Issuer. The Reporting Persons also may consider, formulate, discuss and seek to cause the Issuer to implement various plans or proposals intended to protect, preserve or enhance stockholder value or protect, preserve or enhance the value of the Issuer’s assets, including plans or proposals that may involve extraordinary matters relating to the Issuer. Any such actions or transactions may be taken, advocated by, or involve the Reporting Persons alone or in conjunction with other shareholders, financing sources and/or other third parties, and could include proposing or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D.

 

The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the Issuer’s financial position and strategic direction, actions taken by the Board, price levels of shares of the Common Stock, other investment opportunities available to the Reporting Persons, concentration of positions in the portfolios managed by the Reporting Persons, market conditions and general economic and industry conditions, the Reporting Persons may take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, purchasing additional shares of the Common Stock or other financial instruments related to the Issuer or the Common Stock or selling some or all of the Common Stock, engaging in hedging or similar transactions involving securities relating to the Issuer or the Common Stock and/or otherwise changing their intention with respect to any and all matters referred to in subsections (a) through (j) of Item 4 of Schedule 13D.

 

Item 5. Interest in Securities of the Issuer

 

(a) - (b)

 

Reporting Person Number of Shares with Sole Voting and Dispositive Power Number of Shares with Shared Voting and Dispositive Power Aggregate Number of Shares Beneficially Owned Percentage of Common Stock Beneficially Owned
ASE Technology Holding Co., Ltd. 0 2,312,077 2,312,077 27.4%
ASE Test, Inc. 0 2,312,077 2,312,077 27.4%

 

The May 3, 2024 warrant shares are not included in the table as they are not exercisable for six months from the date of issuance.

 

(c) Except as reported in Item 3 above, the Reporting Persons have not affected any transactions in the shares of Common Stock in the sixty days prior to the date hereof.

 

(d) The information in Item 2 is incorporated by reference into this Item 5(d).

 

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

The Reporting Persons’ responses to Items 3 – 5 are incorporated by reference into this Item 6.

 

ASE Test Taiwan directly holds 29,411 shares of Common Stock.

 

 

 

On March 13, 2023, the Issuer entered into a Convertible Promissory Note Purchase Agreement (the “2023 Agreement”) with ASE Test Taiwan pursuant to which ASE Test Taiwan committed to pay a total aggregate amount of $2,000,000 to the Issuer in exchange for convertible promissory note(s) in three tranches in the amounts of $1,000,000 (the “First Tranche”), $500,000 (the “Second Tranche”), and $500,000 (the “Third Tranche”) conditioned, among other things, on the Issuer achieving certain business milestones. ASE Test Taiwan provided $1,500,000 on as April 12, 2023 and the remaining $500,000 on September 12, 2023. Accordingly, ASE Test Taiwan holds a convertible note that will mature on March 13, 2025 and bears interest at the rate of 6% compounded interest per annum. At any time after the issuance and before the maturity date, the note is convertible into the Issuer's Common Stock at the conversion price of $7.50 per share (or 282,666 shares), subject to anti-dilutive adjustment as set forth in the note.

 

Effective May 3, 2024, Ainos Inc., a Cayman Islands corporation (“Ainos KY”) and ASE Test Taiwan entered into a voting agreement with respect to the voting stock of the Issuer (the "Voting Agreement"). Pursuant to the Voting Agreement, ASE Test Taiwan has agreed to vote all of its current or future acquired voting stock of the Issuer in the manner determined by Ainos KY in its sole discretion. The Voting Agreement will continue in effect until May 3, 2025 and thereafter will automatically renew for additional one-year periods unless ASE Test Taiwan provides prior notice of termination. As part of the Voting Agreement, ASE Test Taiwan agreed that, without Ainos KY’s written consent, it would not sell or transfer more than 20% of its shares of the Issuer in any calendar year period through the fifth anniversary of the date of the Voting Agreement. If, in any calendar year, ASE Test Taiwan does not sell the full 20% allocation, the remaining percentage will be added to and increase the following year's allocation. The transfer restrictions will terminate upon the termination of the Voting Agreement.

 

Except as set forth herein, neither of the Reporting Persons has any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to any contracts, arrangements, understandings or relationships concerning the transfer or voting of such securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

 

Item 7. Material to be Filed as Exhibit

 

Exhibit No. Description
1 *Joint Filing Agreement, dated May 3, 2024, by and between the Reporting Persons.
2.1 Convertible Promissory Note Purchase Agreement, dated March 13, 2023, by and between the Issuer and ASE Test Taiwan in the principal amount of $2,000,000 (incorporated by reference to Exhibit 2.1(a) to the Issuer's Current Report on Form 8-K filed on March 14, 2023).
2.2 Convertible Promissory Note, dated May 3, 2024, issued by the Issuer in favor of ASE Test Taiwan in the principal amount of $9,000,000 (incorporated by reference to Exhibit 4.2 to the Issuer’s Current Report on Form 8-K filed on May 6, 2024).
2.3 Common Stock Warrant, dated May 3, 2024, issued by the Issuer to ASE Test Taiwan (incorporated by reference to Exhibit 4.3 to the Issuer’s Current Report on Form 8-K filed on May 6, 2024).
2.4 Convertible Note and Warrant Purchase Agreement, dated May 3, 2024, by and between the Issuer and ASE Test Taiwan (incorporated by reference to Exhibit 10.1 to the Issuer’s Current Report on Form 8-K (File No. 001-41461) on May 6, 2024).
2.5 Voting Agreement, dated May 3, 2024, by and between Ainos KY and ASE Test Taiwan (incorporated by reference to Exhibit 4.1 to the Issuer’s Current Report on Form 8-K (File No. 001-41461) on May 6, 2024).

____________________

* Filed herewith.

 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: May 8, 2024

 

  ASE TECHNOLOGY HOLDING CO., LTD.
   
   
  By: /s/ Joseph Tung                                     
  Name: Joseph Tung
  Title: Director and Chief Financial Officer
   
  ASE TEST INC.
   
   
  By: /s/ Alan Li                                          
  Name: Alan Li
  Title: Director

  

 

 

 

Schedule A

 

Directors and Executive Officers of ASE Technology Holding Co., Ltd.

 

Name of director

or executive officer

Residence

or business address

Present principal occupation

or employment

Nationality
Jason C.S. Chang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director and Chairman Singapore
Richard H.P. Chang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director, Vice Chairman and President Hong Kong
Chi-Wen Tsai

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director; Chairman and President, Siliconware Precision Industries Co., Ltd. Taiwan
Yen-Chun Chang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director; Chief Operating Officer, Siliconware Precision Industries Co., Ltd. Taiwan
Tien Wu

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director and Chief Operating Officer Taiwan
Joseph Tung

Room 1901, No. 333, Section 1 Keelung Rd.

Taipei, 110, Taiwan,

Republic of China

Director and Chief Financial Officer Taiwan
Raymond Lo

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director; General Manager, ASE Test Taiwan and Kaohsiung packaging facility Taiwan
Tien-Szu Chen

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director; General Manager, Advanced Semiconductor Engineering Inc. Chung-Li branch Taiwan
Rutherford Chang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director; General Manager, China Region of Advanced Semiconductor Engineering Inc. United States
Shen-Fu Yu

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Independent Director and Member, Audit Committee, Compensation Committee, and Risk Management Committee Taiwan
Mei-Yueh Ho

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Independent Director and Member, Audit Committee, and Risk Management Committee Taiwan
Wen-Chyi Ong

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Independent Director and Member, Audit Committee, and Compensation Committee Taiwan
Du-Tsuen Uang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Chief Administration Officer Taiwan
Andrew Tang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Chief Procurement Officer; Vice Chairman, Advanced Semiconductor Engineering Inc. United States
Chun-Che Lee

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, ASE Electronics

Inc.

Taiwan
Chung Lin

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, ASE (Shanghai) Inc. Taiwan

   

 

 

 

Name of director

or executive officer

Residence

or business address

Present principal occupation

or employment

Nationality
Gichol Lee

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, ASE (Korea) Inc. Korea
Chih-Hsiao Chung

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, ASE Japan Co. Ltd. and Wuxi Tongzhi Microelectronics Co., Ltd. Taiwan
Kwai Mun Lee

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

President, ASE South-East Asia operations Singapore
Yean Peng Chen

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, ASE Singapore Pte. Ltd. Singapore
Heng Ee Ooi

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, ASE Electronics (M) Sdn. Bhd. Malaysia
Kenneth Hsiang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Chief Executive Officer, ISE Labs, Inc. and ISE Labs, China, Ltd. United States
Chi-Pin Chang

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Siliconware USA, Inc. Taiwan
Kevin Yu

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Siliconware Technology (Suzhou) Limited Taiwan
Jeffrey Chen

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Director; Chairman, Universal Scientific Industrial (Shanghai) Co., Ltd. Taiwan
Chen-Yen Wei

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Chairman, Universal Scientific Industrial Co., Ltd.; President, Universal Scientific Industrial (Shanghai) Co., Ltd.; General Manager, Universal Global Scientific Industrial Co., Ltd. Taiwan
Ta-I Lin

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Universal Global Technology (Kunshan) Co. Ltd. Taiwan
Jing Cao

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Universal Global Technology (Shanghai) Co., Ltd. United States
Yueh-Ming Lin

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Universal Global Technology (Huizhou) Co., Ltd. Taiwan
Hui-Min Liu

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, UNIVERSAL SCIENTIFIC INDUSTRIAL VIETNAM COMPANY LIMITED Taiwan
Bernardo Santos Balderrama

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Universal Scientific Industrial De Mexico S.A. De C.V. Mexico
Nicolas Denis

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

Chief Executive Officer, Financière AFG France
Ying Pin Wu

26, Chin 3rd Rd.,

Nanzih Dist.,

Kaohsiung, 811, Taiwan

Republic of China

General Manager, Asteelflash Suzhou Co., Ltd. United States

 

 

 

 

Directors and Executive Officers of ASE Test Taiwan

 

Name of director

 

or executive officer

 

Residence

 

or business address

 

Present principal occupation

 

or employment

 

Nationality
Jason C.S. Chang

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director and Chairman Singapore
Rutherford Chang

10, West 5th Street, Nanzih Dist.

, Kaohsiung, 811, Taiwan

Director; General Manager, China Region of  Advanced Semiconductor Engineering Inc. United States
Raymond Lo

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

 Director; General Manager, ASE Test Taiwan and Kaohsiung packaging facility Taiwan
Tien-Szu Chen

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director; General Manager, Advanced Semiconductor Engineering Inc. Chung-Li branch Taiwan
Jeffrey Chen

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director; Chairman, Universal Scientific Industrial (Shanghai) Co., Ltd. Taiwan
Shih Hua Pan

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director Taiwan
Chun Che Lee

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director Taiwan
Jerry Chang

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director

 

United States
Alan Li

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director Taiwan
Alan Cheng

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director Taiwan
Anne Chang

10, West 5th Street, Nanzih Dist.,

Kaohsiung, 811, Taiwan

Director Taiwan